Common side effects of Yurpeak 10mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion)
Otherwise, we use PO vitamin K
The drug remains in active clinical development, with Phase 3 trials currently underway evaluating retatrutide's efficacy and safety across broader populations, including individuals with obesity, type 2 diabetes, and cardiovascular disease
Scientific References TripleHormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial
Novel GLP-1 Mimetics Developed to Treat Type 2 Diabetes Promote Progenitor Cell Proliferation in the Brain
If urgent signs are absent, the clinician can order appropriate labs, suggest conservative measures, and schedule follow-up